Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to confirm there is no significant effect of gastric pH changes of famotidine on the drug levels of afimetoran in healthy participants.
Official title: A Phase 1 Open-label, 2-Part Crossover Study to Assess the Effect of Acid-reducing Agent Famotidine on the Pharmacokinetics of Afimetoran (BMS-986256) in Healthy Participants
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
76
Start Date
2023-07-04
Completion Date
2026-03-01
Last Updated
2025-01-22
Healthy Volunteers
Yes
Conditions
Interventions
Famotidine
Specified dose on specified days
Afimetoran
Specified dose on specified days
Locations (1)
Quotient Sciences
Nottingham, Nottinghamshire, United Kingdom